VEGF/rGel (Targa Therapeutics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameVEGF/rGel (Targa Therapeutics)
Drug Alias NameVEGF/rGel-Op (Taga The)VEGF121/rGel (Targa Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionVascular endothelial growth factor receptor stimulants
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsSolid tumoursMacular DegenerationDiabetic Retinopathy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTarga Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTarga Therapeutics Corp
Active IndicationsN/A
Inactive IndicationsSolid tumoursMacular DegenerationDiabetic Retinopathy +[4] 

Other Information

ATC CodeN/A
Related LinksN/A